Results 41 to 50 of about 472,711 (314)

Cognitive impairment in Parkinson's disease : is it a unified phenomenon? [PDF]

open access: yes, 2005
Parkinson's disease (PD) has long been associated with dementia. This has been found to correlate with participant age, age at onset of PD and severity of PD.
Brendel, Bettina   +2 more
core   +1 more source

Dementia and Parkinson's Disease: Similar and Divergent Challenges in Providing Palliative Care

open access: yesFrontiers in Neurology, 2019
Dementia and Parkinson's disease are incurable neurological conditions. Patients often experience specific, complex, and varying needs along their disease trajectory. Current management typically employs a multidisciplinary team approach.
Jenny T. van der Steen   +11 more
doaj   +1 more source

Additional file 3: of Meta-analysis of risk factors for Parkinsonâ s disease dementia

open access: yes, 2016
Details of factors not included in the meta-analysis. This file provided data of risk factors for Parkinsonâ s disease dementia that were mentioned in literature, but were not included in the meta-analysis due to limited number of studies or differences in study design. (DOCX 93 kb)
Yaqian Xu, Yang, Jing, Huifang Shang
openaire   +1 more source

Mild behavioral impairment in Parkinson's disease: Data from the Parkinson's disease cognitive impairment study (PACOS) [PDF]

open access: yes, 2019
Neuropsychiatric symptoms (NPS) have been frequently described in Parkinson's disease (PD), even in the earliest stages of the disease. Recently the construct of mild behavioral impairment (MBI) has been proposed as an at-risk state for incident ...
Baschi R.   +7 more
core   +1 more source

Biomarkers in Parkinson’s disease: A state of the art review

open access: yesBiomarkers in Neuropsychiatry, 2023
Biomarkers in Parkinson’s disease are widely researched in the field of neuropsychiatry. Though Parkinson’s disease is diagnosed clinically, biomarkers prove to be a promising means to identify disease in early stages, track disease progression, and ...
Kyla Y. Yamashita   +3 more
doaj   +1 more source

Additional file 2: of Meta-analysis of risk factors for Parkinsonâ s disease dementia

open access: yes, 2016
Details of the study results. This file provided detailed results of meta-analysis of each risk factor. (DOCX 159 kb)
Yaqian Xu, Yang, Jing, Huifang Shang
openaire   +1 more source

Investigating the interaction between neuropsychiatry features and daily activities on social function in patients with Parkinson's disease with mild cognitive impairment

open access: yesBJPsych Open, 2022
Background Social functioning is crucial for daily living and is an essential indicator of dementia in patients with Parkinson's disease. The pattern of social functioning in patients with Parkinson's disease without dementia (i.e.
Yi-Ru Chen   +7 more
doaj   +1 more source

Additional file 1: of Meta-analysis of risk factors for Parkinsonâ s disease dementia

open access: yes, 2016
Details of studies included in the meta-analysis. This file included details of all studies included in this meta-analysis, categorized by risk factors. Details including first author, year of publication, country, study design, number of participants and NOS scores. (DOCX 119 kb)
Yaqian Xu, Yang, Jing, Huifang Shang
openaire   +1 more source

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia

open access: yesActa Neuropathologica, 2010
Parkinson’s disease (PD) and dementia with Lewy bodies (DLB) are usually associated with loss of dopaminergic neurons. Loss of substantia nigra neurons and presence of Lewy body inclusions in some of the remaining neurons are the hallmark pathology seen ...
W. Schulz-Schaeffer
semanticscholar   +1 more source

Detecting cognitive impairment in patients with Parkinson's disease using a brief cognitive screening tool: Addenbrooke's Cognitive Examination (ACE)

open access: yesDementia & Neuropsychologia
Detecting cognitive impairment in patients with Parkinson's disease is crucial for good clinical practice given the new therapeutic possibilities available.
Anabel Chade   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy